HG6-64-1 (Synonyms: HMSL 10017-101-1) |
| Katalog-Nr.GC36223 |
HG6-64-1 ist ein potenter und selektiver B-Raf-Inhibitor, extrahiert aus Patent WO 2011090738 A2, Beispiel 9 (XI-1); hat einen IC50 von 0,09 μM auf B-raf V600E-transformierten Ba/F3-Zellen.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1315329-43-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
HG6-64-1 is a potent and selective B-Raf inhibitor extracted from patent WO 2011090738 A2, example 9 (XI-1); has a IC50 of 0.09 μM on B-raf V600E transformed Ba/F3 cells. B-RafV600E|0.09 μM (IC50, in Ba/F3 cells)
[1]. WO 2011090738 A2
Average Rating: 5 (Based on Reviews and 8 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *